Breast cancer displays varying biological characteristics and trajectories across its subtypes: HR + HER2-BC (hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer), HER2 + BC, and triple-negative breast cancer (TNBC). This evidence concerns the gene NR4A1 and breast carcinoma.